Categoria
USAF EA-2
Nombres de marca,
USAF EA-2
Analogos
USAF EA-2
Marca los nombres de mezcla
No information avaliable
USAF EA-2
Formula quimica
C8H6N4O5
USAF EA-2
RX enlace
http://www.rxlist.com/cgi/generic/nitro25m.htm
USAF EA-2
FDA hoja
USAF EA-2
MSDS (hoja de seguridad de materiales)
USAF EA-2
Sintesis de referencia
No hay información disponible
USAF EA-2
Peso molecular
238.157 g/mol
USAF EA-2
Punto de fusion
263 oC
USAF EA-2
H2O Solubilidad
79.5 mg / L
USAF EA-2
Estado
Solid
USAF EA-2
LogP
-0.04
USAF EA-2
Formas de dosificacion
Tableta
USAF EA-2
Indicacion
Para el tratamiento de la infección del tracto urinario
USAF EA-2
Farmacologia
Nitrofurantoína, un agente antibacteriano nitrofuranos, está disponible en forma microcristalina y macrocristalinas para tratar las infecciones del tracto urinario causada por muchas bacterias gram-negativas y algunas bacterias gram-positivas.
USAF EA-2
Absorcion
No hay información disponible
USAF EA-2
Toxicidad
No hay información disponible
USAF EA-2
Informacion de Pacientes
Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further
enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy;
however, they should be advised to contact their physician if any unusual symptoms occur during therapy.
Patients should be advised not to use antacid preparations containing magnesium trisilicate while
taking Macrobid.
Patients should be counseled that antibacterial drugs including Macrobid should only be used to
treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is
prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in
the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full
course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that
bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the
future.
USAF EA-2
Organismos afectados
Gram negativos y algunas bacterias gram positivas